PMV Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 11/14/2024 | 6.48 M | $9.65 M | 0.00% | 12.56% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2024 | 3.65 M | $5.43 M | 30.04% | 7.07% |
| SIO CAPITAL MANAGEMENT, LLC | 11/14/2024 | 3.21 M | $4.79 M | 18.68% | 6.23% |
| EUCLIDEAN CAPITAL LLC | 11/14/2024 | 2.63 M | $3.92 M | 0.00% | 5.09% |
| ALKEON CAPITAL MANAGEMENT LLC | 11/14/2024 | 2.34 M | $3.49 M | -0.07% | 4.54% |
| VANGUARD GROUP INC | 11/13/2024 | 2.28 M | $3.40 M | -0.06% | 4.42% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 2.08 M | $3.09 M | 0.00% | 4.03% |
| PFM HEALTH SCIENCES, LP | 11/14/2024 | 2.01 M | $3.00 M | 57.67% | 3.90% |
| BML CAPITAL MANAGEMENT, LLC | 11/05/2024 | 1.69 M | $2.52 M | 28.97% | 3.27% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.14 M | $1.71 M | 100.00% | 2.22% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1.06 M | $1.57 M | -38.50% | 2.05% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 1.04 M | $1.55 M | 2.04% | 2.02% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 751,200 | $1.12 M | 52.22% | 1.46% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 705,593 | $1.05 M | -9.43% | 1.37% |
| PERSONAL CFO SOLUTIONS, LLC | 11/14/2024 | 550,342 | $820,010 | 0.00% | 1.07% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 510,004 | $759,906 | -36.94% | 0.99% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 483,055 | $719,752 | 24.40% | 0.94% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 441,024 | $657,126 | 0.43% | 0.86% |
| ACUITAS INVESTMENTS, LLC | 11/07/2024 | 440,687 | $656,624 | 24.58% | 0.85% |
| ALDEBARAN CAPITAL, LLC | 11/13/2024 | 438,252 | $652,995 | 24.77% | 0.85% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 432,762 | $644,959 | 1.18% | 0.84% |
| M&T BANK CORP | 11/19/2024 | 399,548 | $595,663 | 54.57% | 0.77% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 363,969 | $542,314 | -52.03% | 0.71% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 353,837 | $527,217 | 36.08% | 0.69% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 322,024 | $479,816 | 0.00% | 0.62% |
| RBF CAPITAL, LLC | 11/14/2024 | 253,361 | $388,345 | 0.00% | 0.49% |
| SHAY CAPITAL LLC | 11/14/2024 | 188,051 | $280,196 | 13.69% | 0.36% |
| UBS GROUP AG | 11/14/2024 | 178,866 | $266,510 | 110.67% | 0.35% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 145,737 | $217,148 | 0.00% | 0.28% |
| STATE STREET CORP | 11/14/2024 | 145,078 | $216,166 | 0.00% | 0.28% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 139,900 | $208,451 | 0.00% | 0.27% |
| EVOKE WEALTH, LLC | 11/13/2024 | 133,122 | $198,352 | 110.53% | 0.26% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 126,004 | $187,760 | 0.00% | 0.24% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 120,770 | $179,947 | -64.52% | 0.23% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 101,008 | $150,502 | 102.02% | 0.20% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 89,631 | $133,550 | 100.00% | 0.17% |
| JANE STREET GROUP, LLC | 11/15/2024 | 74,089 | $110,393 | -54.84% | 0.14% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 73,352 | $109,000 | -5.65% | 0.14% |
| PNC FINANCIAL SERVICES GROUP, INC. | 11/08/2024 | 69,229 | $103,151 | 60.08% | 0.13% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 66,900 | $99,681 | -48.30% | 0.13% |
| MARQUETTE ASSET MANAGEMENT, LLC | 10/08/2024 | 64,009 | $95,374 | 0.00% | 0.12% |
| MARSHALL WACE, LLP | 11/14/2024 | 61,691 | $91,920 | 378.22% | 0.12% |
| MORGAN STANLEY | 11/14/2024 | 59,421 | $88,538 | -50.17% | 0.12% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 44,160 | $65,798 | -49.02% | 0.09% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 43,293 | $64,507 | -15.32% | 0.08% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 39,522 | $58,888 | -20.63% | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2024 | 37,100 | $55,279 | -72.46% | 0.07% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 33,600 | $51,000 | 0.00% | 0.07% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 11/14/2024 | 32,190 | $47,963 | -48.61% | 0.06% |
| BARCLAYS PLC | 11/19/2024 | 30,248 | $45,000 | -93.49% | 0.06% |
PMV Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 101 institutional investors and hedge funds held shares of PMV Pharmaceuticals, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 6.48 M
ArrowMark Colorado Holdings LLC: 3.65 M
Sio Capital Management, LLC: 3.21 M
Euclidean Capital LLC: 2.63 M
ALKEON CAPITAL MANAGEMENT LLC: 2.34 M
VANGUARD GROUP INC: 2.28 M
75.67% of PMV Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 42.17 M shares in the last 24 months. This purchase volume represents approximately $56.93 M in transactions.